About Zymetis

Zymetis, Inc. is a biotechnology company dedicated to developing novel enzyme products for the emerging bio-refining and white chemistry industries. Derived from unique organisms, Zymetis products and processes are designed to achieve lower costs, improved yields and higher manufacturing efficiencies in the conversion of cellulosic biomass to usable sugars. Currently, Zymetis is focused on the production of affordable next-generation transportation fuels, however its technology can be integrated into any process seeking to ferment sugars derived from cellulosic sources.

Vision and Mission

At Zymetis, we envision a world where sustainable energy fuels all human activity. That’s why it’s our mission to develop innovative biotechnologies to enable the economical production of cost-effective alternatives to fossil fuel.

History

Zymetis was formed in 2006 to commercialize technologies discovered by Dr. Steve Hutcheson, professor of cell biology and molecular genetics, and Dr. Ron Weiner, Professor Emeritus, from the University of Maryland.  Dr. Hutcheson made the decision to lead the company through its early days and began by licensing several patents and patents-pending from the University.

Zymetis participated in the University’s VentureAccelerator spin-out program and located in the Technology Advancement Program (TAP) building on the University’s College Park campus. TAP is a leading venture incubator that partners with regional entrepreneurs to build early-stage companies. At this location, Zymetis has access to dedicated lab facilities for all necessary technology development and a talented pool of recent graduates and student interns seeking to transition to the industrial world.

Today, Zymetis has a growing full time staff of research scientists working to develop and refine the company’s initial product offerings.

Awards

Investors

Zymetis is a privately-held company.